OptimizeRx (OPRX) Short Interest Ratio & Short Volume $4.91 +0.16 (+3.37%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends OptimizeRx Short Interest DataOptimizeRx (OPRX) has a short interest of 1.00 million shares, representing 6.27% of the float (the number of shares available for trading by the public). This marks a -5.66% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.2, indicating that it would take 4.2 days of the average trading volume of 162,423 shares to cover all short positions.Current Short Interest1,000,000 sharesPrevious Short Interest1,060,000 sharesChange Vs. Previous Month-5.66%Dollar Volume Sold Short$5.45 millionShort Interest Ratio4.2 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares18,421,000 sharesFloat Size15,960,000 sharesShort Percent of Float6.27%Today's Trading Volume290,325 sharesAverage Trading Volume162,423 sharesToday's Volume Vs. Average179% Short Selling OptimizeRx? Sign up to receive the latest short interest report for OptimizeRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOPRX Short Interest Over TimeOPRX Days to Cover Over TimeOPRX Percentage of Float Shorted Over Time Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. OptimizeRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20241,000,000 shares $5.45 million -5.7%6.3%4.2 $5.45 11/15/20241,060,000 shares $4.05 million +10.8%6.6%5 $3.83 10/31/2024956,300 shares $4.99 million +4.8%6.0%7.4 $5.22 10/15/2024912,500 shares $5.93 million +8.7%5.8%7.2 $6.50 9/30/2024839,400 shares $6.48 million -2.9%5.3%6.9 $7.72 9/15/2024864,500 shares $6.74 million +0.1%5.4%7.2 $7.80 Get the Latest News and Ratings for OPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024863,700 shares $7.18 million -8.2%5.4%7.4 $8.31 8/15/2024941,000 shares $7.90 million +1.0%5.9%7.9 $8.40 7/31/2024931,700 shares $10.16 million -7.8%5.9%7.1 $10.91 7/15/20241,010,000 shares $10.39 million No Change6.4%7.5 $10.29 6/30/20241,010,000 shares $10.10 million -1.0%6.4%7.4 $10.00 6/15/20241,020,000 shares $11.22 million -1.0%6.4%7.3 $11.00 5/31/20241,030,000 shares $12.42 million +12.5%6.4%6.7 $12.06 5/15/2024916,000 shares $12.06 million +12.7%5.7%6 $13.17 4/30/2024812,500 shares $8.29 million +29.7%5.1%6.1 $10.20 4/15/2024626,600 shares $6.47 million -4.5%3.9%5.2 $10.32 3/31/2024656,000 shares $7.97 million -13.1%4.1%5.5 $12.15 3/15/2024754,700 shares $9.58 million -3.3%4.7%6.4 $12.69 2/29/2024780,500 shares $12.36 million +0.3%4.9%5.6 $15.83 2/15/2024778,200 shares $12.38 million -0.1%4.9%5.5 $15.91 1/31/2024778,800 shares $11.00 million -19.6%4.9%4.8 $14.12 1/15/2024968,400 shares $14.31 million +1.3%6.1%5.4 $14.78 12/31/2023956,300 shares $13.68 million -0.1%6.0%5.1 $14.31 12/15/2023957,200 shares $10.56 million -1.0%6.0%5.2 $11.03 11/30/2023967,100 shares $9.20 million +5.0%N/A6.1 $9.51 11/15/2023921,300 shares $8.88 million +5.7%N/A5.2 $9.64 10/31/2023871,400 shares $7.02 million +10.7%N/A4.5 $8.06 10/15/2023787,000 shares $6.68 million +7.6%5.0%4.7 $8.49 9/30/2023731,300 shares $5.69 million +8.1%4.6%5 $7.78 9/15/2023676,600 shares $5.66 million +8.3%4.2%4.7 $8.37 8/31/2023624,800 shares $5.32 million -11.2%3.9%4.6 $8.52 8/15/2023703,200 shares $6.39 million -4.3%4.4%5.6 $9.08 7/31/2023734,600 shares $10.25 million +2.8%4.5%6.9 $13.95 7/15/2023714,700 shares $10.53 million -3.1%4.3%6.3 $14.74 6/30/2023737,900 shares $10.54 million -10.9%4.5%6.1 $14.29 6/15/2023827,700 shares $12.43 million +14.6%5.1%6.2 $15.02 5/31/2023722,100 shares $10.14 million +1.6%4.4%3 $14.04 5/15/2023710,500 shares $9.29 million -19.7%4.3%2.8 $13.08 4/30/2023884,500 shares $13.29 million -3.7%5.4%3.6 $15.03 4/15/2023918,000 shares $13.23 million -14.2%5.6%3.7 $14.41We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol 3/31/20231,070,000 shares $15.65 million -24.7%6.6%4.2 $14.63 3/15/20231,420,000 shares $18.37 million -4.7%8.7%5.6 $12.94 2/28/20231,490,000 shares $26.60 million -6.3%9.1%8.2 $17.85 2/15/20231,590,000 shares $29.03 million +3.3%9.7%11 $18.26 1/31/20231,540,000 shares $27.64 million +29.4%9.4%8.7 $17.95 1/15/20231,190,000 shares $22.04 million +3.5%7.3%6.5 $18.52 12/30/20221,150,000 shares $19.32 million +8.5%7.0%6.1 $16.80 12/15/20221,060,000 shares $18.56 million +3.9%6.5%5.4 $17.51 11/30/20221,020,000 shares $21.51 million -9.7%6.2%5.1 $21.09 11/15/20221,130,000 shares $24.91 million +2.7%6.9%5.4 $22.04 10/31/20221,100,000 shares $16.96 million +0.9%N/A4.2 $15.42 10/15/20221,090,000 shares $15.01 million +11.2%6.6%4.1 $13.77 9/30/2022980,000 shares $14.52 million -1.7%5.9%3.5 $14.82 9/15/2022996,800 shares $15.53 million +3.7%6.0%3.6 $15.58 8/31/2022961,500 shares $15.26 million -10.1%6.1%3.7 $15.87 8/15/20221,070,000 shares $16.69 million -12.3%6.7%4.3 $15.60 7/31/20221,220,000 shares $27.41 million -12.9%7.7%6.4 $22.47 7/15/20221,400,000 shares $41.10 million -4.1%8.8%7.1 $29.36 6/30/20221,460,000 shares $39.99 million +13.2%15.2%8.2 $27.39 6/15/20221,290,000 shares $34.31 million +5.7%13.4%7.2 $26.60 5/31/20221,220,000 shares $31.21 million +9.9%7.7%7 $25.58 5/15/20221,110,000 shares $27.88 million -3.5%7.0%6 $25.12 4/30/20221,150,000 shares $32.33 million -17.3%7.2%6.1 $28.11 4/15/20221,390,000 shares $54.13 million -5.4%8.9%7.7 $38.94 3/31/20221,470,000 shares $55.43 million -9.3%9.4%7.4 $37.71 3/15/20221,620,000 shares $59.44 million +14.9%10.4%7.3 $36.69 2/28/20221,410,000 shares $63.86 million +19.5%9.0%5.6 $45.29 2/15/20221,180,000 shares $57.38 million -1.7%7.6%4.5 $48.63 1/31/20221,200,000 shares $53.92 million +0.8%7.7%4.3 $44.93 1/15/20221,190,000 shares $59.12 million -7.0%7.7%4.3 $49.68 12/31/20211,280,000 shares $79.50 million +3.2%8.2%4.9 $62.11 12/15/20211,240,000 shares $68.91 million -15.1%8.0%3.3 $55.57 11/30/20211,460,000 shares $94.90 million -0.7%9.4%4 $65.00 11/15/20211,470,000 shares $117.73 million -13.0%9.5%4.2 $80.09 10/29/20211,690,000 shares $163.42 million -1.7%11.0%5.4 $96.70 10/15/20211,720,000 shares $145.55 million +35.4%11.2%5.4 $84.62 9/30/20211,270,000 shares $108.65 million +19.8%8.3%4.2 $85.55 9/15/20211,060,000 shares $71.00 million -2.8%6.9%6.3 $66.98 8/31/20211,090,000 shares $72.14 million +9.7%7.1%7.3 $66.18 8/13/2021994,100 shares $61.75 million +13.1%6.5%6.7 $62.12 7/30/2021879,000 shares $48.58 million -2.8%5.8%5.7 $55.27 7/15/2021904,400 shares $46.06 million -2.0%6.0%6.1 $50.93 6/30/2021923,200 shares $57.15 million +5.1%6.6%5.8 $61.90 6/15/2021878,500 shares $45.75 million -3.3%5.9%5 $52.08 5/28/2021908,600 shares $44.63 million -3.7%6.1%4.4 $49.12 5/14/2021943,800 shares $40.36 million -3.0%N/A3.9 $42.76 4/30/2021972,800 shares $48.85 million -2.6%N/A3.3 $50.22 4/15/2021999,200 shares $50.16 million -1.1%N/A3.4 $50.20 3/31/20211,010,000 shares $46.84 million +13.9%N/A3.4 $46.38 3/15/2021887,100 shares $40.18 million +1.9%N/A3.1 $45.29We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol 2/26/2021871,000 shares $48.78 million -6.4%N/A3.4 $56.01 2/12/2021930,300 shares $50.21 million -9.7%N/A4.3 $53.97 1/29/20211,030,000 shares $48.65 million +4.2%8.2%5.5 $47.23 1/15/2021988,900 shares $39.55 million +7.1%7.9%6.3 $39.99 12/31/2020923,400 shares $28.81 million -4.9%7.5%6.1 $31.20 12/15/2020971,000 shares $28.37 million -10.9%7.8%5.7 $29.22 11/30/20201,090,000 shares $27.41 million -7.6%8.8%6.3 $25.15 11/15/20201,180,000 shares $28.74 million -1.7%9.5%7 $24.36 10/30/20201,200,000 shares $24.20 million -3.2%9.7%7.3 $20.17 10/15/20201,240,000 shares $26.90 million +3.3%10.1%7.2 $21.69 9/30/20201,200,000 shares $25.02 million +3.5%9.8%7.4 $20.85 9/15/20201,160,000 shares $23.49 million -3.3%9.6%8.5 $20.25 8/31/20201,200,000 shares $24.19 million -4.0%9.9%8.7 $20.16 8/14/20201,250,000 shares $22 million +21.4%10.3%8.5 $17.60 7/31/20201,030,000 shares $14.57 million +1.0%8.5%7.4 $14.15 7/15/20201,020,000 shares $15.24 million -1.9%8.5%7.7 $14.94 6/30/20201,040,000 shares $13.43 million +22.2%8.7%7.8 $12.91 6/15/2020851,300 shares $10.93 million -4.1%7.1%6.6 $12.84 5/29/2020888,000 shares $10.24 million -0.4%7.4%7.3 $11.53 5/15/2020891,400 shares $8.47 million +1.4%7.4%7.7 $9.50 4/30/2020878,800 shares $8.18 million -1.3%7.3%8.4 $9.31 4/15/2020890,700 shares $8.16 million +2.1%7.4%8.9 $9.16 3/31/2020872,000 shares $8.29 million -4.9%7.3%9.2 $9.51 3/13/2020916,600 shares $7.75 million +11.4%7.8%7.5 $8.46 2/28/2020823,200 shares $5.84 million -4.1%7.0%9 $7.10 2/14/2020858,700 shares $6.22 million +7.7%7.5%10.5 $7.24 1/31/2020797,700 shares $9.01 million +8.7%6.9%8.8 $11.29 1/15/2020734,200 shares $7.80 million -13.2%6.4%6.8 $10.62 12/31/2019845,500 shares $8.64 million -0.5%7.3%7.9 $10.22 OPRX Short Interest - Frequently Asked Questions What is OptimizeRx's current short interest? Short interest is the volume of OptimizeRx shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 1,000,000 shares of OPRX short. 6.27% of OptimizeRx's shares are currently sold short. Learn More on OptimizeRx's current short interest. What is a good short interest ratio for OptimizeRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OPRX shares currently have a short interest ratio of 4.0. Learn More on OptimizeRx's short interest ratio. What is a good short interest percentage for OptimizeRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.27% of OptimizeRx's floating shares are currently sold short. Is OptimizeRx's short interest increasing or decreasing? OptimizeRx saw a decrease in short interest in November. As of November 30th, there was short interest totaling 1,000,000 shares, a decrease of 5.7% from the previous total of 1,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is OptimizeRx's float size? OptimizeRx currently has issued a total of 18,421,000 shares. Some of OptimizeRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. OptimizeRx currently has a public float of 15,960,000 shares. How does OptimizeRx's short interest compare to its competitors? 6.27% of OptimizeRx's shares are currently sold short. Here is how the short interest of companies in the industry of "business services" compare to OptimizeRx: 8x8, Inc. (5.74%), IBEX Limited (1.13%), Accolade, Inc. (3.90%), Resources Connection, Inc. (3.19%), Armlogi Holding Corp. (0.80%), Rimini Street, Inc. (3.05%), Akso Health Group (0.01%), HireQuest, Inc. (2.63%), Nutex Health Inc. (1.43%), Perma-Fix Environmental Services, Inc. (6.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short OptimizeRx stock? Short selling OPRX is an investing strategy that aims to generate trading profit from OptimizeRx as its price is falling. OPRX shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against OptimizeRx? A short squeeze for OptimizeRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OPRX, which in turn drives the price of the stock up even further. How often is OptimizeRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPRX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies EGHT Short Squeeze IBEX Short Squeeze ACCD Short Squeeze RGP Short Squeeze BTOC Short Squeeze RMNI Short Squeeze AHG Short Squeeze HQI Short Squeeze NUTX Short Squeeze PESI Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OPRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
